Purdue Settles Ark. Fund's OxyContin Antitrust Suit
An employee benefits fund in Arkansas has settled a suit accusing Purdue Pharmaceuticals LP of blocking generic competition by filing bogus patent litigation over OxyContin, marking the latest agreement in the...To view the full article, register now.
Already a subscriber? Click here to view full article